FDA-Drug2017-03-01Class II
Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02
RemedyRepack Inc.
Hazard
Failed Dissolution Specifications
Sold states
Product was distributed to a sold customer in FL.
Affected count
630 pills (21 bottles x 30 pills per HDPE bottle)
Manufactured in
625 Kolter Dr Ste 4, N/A, Indiana, PA, United States
Products
Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0482-2017Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief